Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Published:2021-10-13 Issue:11 Volume:41 Page:941-953
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Escobar Carlos^ORCID,Barrios Vivencio,Lip Gregory Y. H.,Amin Alpesh N.,Auladell-Rispau Ariadna,Santero Marilina,Salazar Josefina,Requeijo Carolina

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-021-01091-w.pdf

Reference61 articles.

1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. ESC Scientific Document Group. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020. https://doi.org/10.1093/eurheartj/ehaa612.

2. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2019 update: a report from the American. Heart Association. Circulation. 2019;139:e56-528. https://doi.org/10.1161/CIR.0000000000000659.

3. Ceornodolea AD, Bal R, Severens JL. Epidemiology and management of atrial fibrillation and stroke: review of data from four European countries. Stroke Res Treat. 2017;2017:8593207. https://doi.org/10.1155/2017/8593207.

4. Barrios V, Escobar C, Calderon A, Rodríguez Roca GC, Llisterri JL, Polo GJ. Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care. Rev Esp Cardiol. 2014;67:150–1. https://doi.org/10.1016/j.rec.2013.07.009.

5. Ma C, Riou França L, Lu S, Diener HC, Dubner SJ, Halperin JL, et al. GLORIA-AF Investigators. Stroke prevention in atrial fibrillation changes after dabigatran availability in China: the GLORIA-AF registry. J Arrhythm. 2020;36:408–16. https://doi.org/10.1002/joa3.12321 (eCollection 2020 Jun).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Situación actual de los anticoagulantes orales de acción directa en atención primaria de España. Posicionamiento de SEMERGEN en 2023;Medicina de Familia. SEMERGEN;2024-04

2. Safety of dabigatran;Glavvrač (Chief Medical Officer);2024-01-22

3. Comparative safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation: A network meta-analysis;Journal of the Formosan Medical Association;2023-11

4. Contemporary Perioperative Management of Direct Oral Anticoagulants;Advances in Anesthesia;2022-12

5. The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation;BMC Cardiovascular Disorders;2022-11-11